Altered Cd36 expression is associated with NAFLD, and directly contributes to the development of fatty liver under conditions of elevated FFA by modulating the rate of FA uptake by hepatocytes (37). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.